Another study in Henan province, China conducted by Li-Ya15 and his colleagues stated that p53 mutations were detected in 40.9% of their esophageal cancer specimens and this is compatible with our finding on mutations being detected in 20 out of 50 specimens of esophageal carcinomas which represent 40%. This evidence concerns the gene TP53 and carcinoma of esophagus.